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Abstract
Differential scanning fluorometry (DSF), also referred to as fluorescence thermal shift, is emerging as a convenient method
to evaluate the stabilizing effect of small molecules on proteins of interest. However, its use in the mechanism of action
studies has received far less attention. Herein, the ability of DSF to report on inhibitor mode of action was evaluated using
glutathione S-transferase (GST) as a model enzyme that utilizes two distinct substrates and is known to be subject to a
range of inhibition modes. Detailed investigation of the propensity of small molecule inhibitors to protect GST from thermal
denaturation revealed that compounds with different inhibition modes displayed distinct thermal shift signatures when
tested in the presence or absence of the enzyme’s native co-substrate glutathione (GSH). Glutathione-competitive inhibitors
produced dose-dependent thermal shift trendlines that converged at high compound concentrations. Inhibitors acting via
the formation of glutathione conjugates induced a very pronounced stabilizing effect toward the protein only when GSH
was present. Lastly, compounds known to act as noncompetitive inhibitors exhibited parallel concentration-dependent
trends. Similar effects were observed with human GST isozymes A1-1 and M1-1. The results illustrate the potential of DSF as
a tool to differentiate diverse classes of inhibitors based on simple analysis of co-substrate dependency of protein
stabilization.
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Introduction
A range of biophysical techniques are used to evaluate direct
binding between a ligand (most frequently, a small molecule) and a
target protein, and these can be based on calorimetry, surface
immobilization, separation, or direct spectroscopic methods [1]. A
general method to evaluate compound-protein interaction is based
on the ability of equilibrium binding ligand to perturb the protein
stability upon application of a destabilizing factor, such as
temperature, denaturing chemical, or proteolytic enzyme [1].
Although many techniques, such as NMR, MS or calorimetry, can
monitor ligand-induced protein perturbation, their utility is often
limited by complexity and requirements for high protein
consumption [1,2]. A method that overcomes some of these
limitations is the fluorescence-based thermal shift assay, also
known as differential scanning fluorometry (DSF). In DSF, an
environmentally sensitive fluorescence dye whose quantum yield
increases upon binding to hydrophobic protein regions is applied
to monitor protein conformational stability upon thermal
denaturation [3,4]. By coupling ligand binding to protein
unfolding, protein Gibbs free energy of unfolding is increased,
usually resulting in an increase in protein melting temperature,
Tm, which in turn can be used as an indicator of a direct protein
binder.
Execution of DSF does not involve any modification of the
protein target or separation steps, and it does not require any prior
knowledge of (but may assist to elicit) protein function
[2,3,5,6,7,8,9]. DSF has been used to assist with refining protein
crystallization conditions and has been reported to allow the
determination of ligand-binding affinity [10,11] or binding
stoichiometry [11]. Tm shift has been shown to correlate well
with enzyme inhibition data or binding affinities derived from
other methods [12,13,14]. Two recent studies exemplify the use of
DSF to conduct more complex studies, such as the probing of co-
factor dependencies of inhibitor binding to 15-hydroxyprostaglan-
din dehydrogenase [15] and the demonstration of an enhanced
stabilization effect on firefly luciferase reporter through reaction
between the small molecule agent PTC124 and ATP [16]. Despite
these advances, the majority of uses of DSF have been confined to
prioritization of ligands for X-ray crystallography, as well as
limited medium-throughput screening, typically executed at a
single compound concentration.
We wished to further leverage the information provided by DSF
and, in particular, to explore its ability to distinguish inhibitors
acting by different mechanisms. To this end, we used glutathione
S-transferase (GST) as a model enzyme for a relatively complex
reaction involving two distinct substrates and known for being
inhibited through a range of mechanisms. GSTs contribute to the
phase II biotransformation of xenobiotics in a variety of
organisms, with members of the family being involved in both
the metabolism and transportation of potentially toxic ligands.
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conjugation of a variety of electrophiles with glutathione (c-Glu-
Cys-Gly, GSH) by GST or ligandin binding ability of GST with a
range of lipophilic chemicals [17]. Based on sequence similarity
and substrate specificity, human cytosolic GSTs are generally
divided into 5 classes, designated as alpha (A class), mu (M class),
pi (P class), theta (T class) and kappa (K class) [18]. GSTs have also
been detected in a range of pathogenic helminths, such as
Schistosoma worms, and in the malarial parasite Plasmodium
falciparum. GSTs have been extensively studied for their association
with cancer. Genetic polymorphisms in human GSTs have been
linked with oxidative DNA damage and subsequently an increased
risk of cancer susceptibility [19], while schistosomal GSTs have
been considered as potential components in vaccines [20] and as
targets for schistosomiasis drug therapy [21]. Schistosoma japonicum
glutathione S-transferase (EC 2.5.1.18) (SjGST) is also a commonly
used fusion tag in recombinant protein production [22].
A number of apo-protein structures of human [23,24] and
Schistosoma japonicum [21,25] have been published, as well as
structures of protein-ligand complexes [26,27,28,29]. GSTs are
either homo- or heterodimers, with an active site in each
monomer. Each subunit contains two domains, an N-terminal
a/b domain and a C-terminal a-helical domain. A highly selective
glutathione-binding site (G site) is located in the N-terminal
domain and a larger hydrophobic substrate-binding site (H site) is
located in the C-terminal domain. Although the former is more
conserved across different classes than the latter [30,31,32], the
two adjacent sites work together to promote GSH conjugation
with electrophilic substrates. Additionally, a non-substrate ligand
transport site (L site), suggested to be not completely hydrophobic,
has been identified for SjGST [21] and a human p class GST [33],
and a large variability in its location among different species has
been observed.
GST inhibitors have been demonstrated as chemosensitisers to
potentiate anticancer agents [31]. In addition, the discovery of
GSTs’ regulation in signal transduction pathways through specific
protein-protein interactions (PPIs), such as the interruption of the
cJun/MAPK pathway by GSTP1-1 [34,35] and the formation of
inhibitory complexes with the apoptotic stress kinase ASK1 by
GSTM1-1 [36], provides a rationale in the design of GST
inhibitors to potentially disrupt PPIs. Several types of GST
inhibitors are known and, based on their binding site and
inhibition mechanism, they are generally categorized into the
following classes. One type is represented by GSH analogs and
mimetics, which compete with both GSH and hydrophobic
substrates by occupying both the G-site and the H-site [37]. The
second class is comprised of certain electrophilic substrates, which
bind in the hydrophobic region of the H-site and form tight
complexes with GST through the formation of adducts with the
GSH co-substrate [37,38]. In addition, a number of compounds
are found to be noncompetitive inhibitors with respect to both
GSH and electrophilic substrate and they are believed to partially
occupy either the H-site or the intersubunit cleft of the GST dimer
[37,38]. As the nature of the binding site for this type of inhibitors
is less defined, this type of inhibitors is also referred to as ligandin
type inhibitors and their binding site has been named the ligandin
site [17].
The availability of multiple types of GST inhibitors presents this
enzyme class as an attractive model to dissect ligand-dependent
protein stabilization effects, and to further evaluate the ability of
DSF as a tool to provide insight on compound mechanism of
action. Herein, different classes of GST inhibitors were selected,
and their effects on thermal stability of SjGST and the human
GST A1 and M1 were examined. Protein thermal stability was
measured in the presence of multi-point dilution series of
inhibitors; further, DSF signatures obtained in the absence and
presence of GSH were evaluated for indication of compound
mechanism of action.
Materials and Methods
General reagents
HEPES buffer (pH 7.5) was purchased from Teknova. Tween-
20 and glutathione (GSH) were obtained from Sigma-Aldrich (St
Louis, MO). Dimethylsulfoxide (DMSO, certified ACS grade) was
obtained from Fisher, Inc. All compounds were formulated as
10 mM DMSO stock solutions. The buffer used for both the
enzymatic and the thermal shift assay was 50 mM HEPES,
pH 7.5, except that Tween-20 was present in the enzymatic assay
at a final concentration of 0.01%. The fluorescent dye used in the
thermal shift experiments, SYPRO Orange, was obtained from
Life Technologies (Carlsbad, CA) as a 50006stock concentration
(molar concentration of the stock is not provided by the vendor),
and was diluted in the assay buffer to a final concentration of 56.
GST enzymes, substrates, and inhibitors
Sj26GST was purchased from GenScript (Piscataway, NJ).
Human GST isozymes, hGST A1-1 and hGST M1-1, were
procured from Oxford Biomedical Research (Oxford, MI). The
masked proluciferin substrate PBI 1155 [39] and the inhibitors
NBD-8-OH [40], NBD-GS [41], and Bis-(NB-GS) [38] were
purchased from Promega, Inc. (Madison, WI). S-methyl GSH, S-
butyl GSH, S-hexyl GSH, S-octyl GSH, ethacrynic acid (EA),
quercetin, myricetin and tannic acid were obtained from Sigma (St
Louis, MO).
SjGST enzymatic assays
Compound inhibitory activities were evaluated using a
previously reported GST enzymatic assay [39]. Three mlo f
reagents (5 nM final concentration of SjGST (or buffer serving as a
no-enzyme control) plus 100 mM final concentration of GSH) were
dispensed into 1536-well Greiner white solid-bottom assay plates.
Compounds (23 nL) were transferred via Kalypsys pintool
equipped with 1,536-pin array [42]. The plates were incubated
at room temperature for 15 min before the addition of 20 mM
substrate PBI 1155 to initiate the reaction. The plates were
centrifuged at 1000 rpm for 15 s and incubated at room
temperature for 40 min before the addition 4 ml luciferin detection
reagent followed by another 15-s centrifugation at 1000 rpm and
15-min incubation. The plates were then read on ViewLux high-
throughput CCD imager (PerkinElmer, Waltham, MA) with a
clear emission filter and under standard luminescence settings.
Percent inhibition was calculated based on the enzyme-containing
and no-enzyme controls using Excel and GraphPad Prism 4.
Thermal shift assays
Compounds were diluted (1:2, 7-points) in DMSO row-wise
down to 10 mM in a 96-well polypropylene round bottom mother
plate, with DMSO alone in the first column of each plate. After
distributing 49 ml SjGST (1 mM final concentration) and SYPRO
Orange (56final concentration) mixture into the wells of a 96-well
thin wall PCR plate (Bio-Rad, Hercules, CA), compounds (1 ml)
were transferred from the mother plate to the PCR plate with the
final concentrations ranging from 0.2 to 200 mM; DMSO was
included as a vehicle control at a final concentration of 2% (vol/
vol), a suggested value for thermal shift experiment [7]; the
inclusion of 2% DMSO resulted in only a marginal decrease in the
SjGST Tm of 0.95+0.07uC (n=2) (data not shown). The PCR
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mixing, and sealed with Optical-Quality Sealing Tape (Bio-Rad).
The plates were subsequently heated approximately 2 min after
sample mixing, on an iQ5 thermal cycler at intervals of 1uC from
20 to 95uC, with a ramping rate of 6uC min
21. The set-up of the
filter configurations was customized to accommodate the optimal
excitation and emission wavelengths for SYPRO Orange (Ex:
490/Em: 575 nm). The mid temperature of the protein thermal
melt profiles, Tm, was determined using EXCEL-based custom
calculation software available at (ftp://ftp.sgc.ox.ac.uk/pub/
biophysics), and fitting of the data to the Boltzmann equation
was performed using GraphPad Prism 4. The differences in Tm
between vehicle control and compound-containing samples were
calculated as thermal shift.
Figure 1. GST inhibitors tested in this study and their inhibitory activity against SjGST.
doi:10.1371/journal.pone.0036219.g001
Figure 2. Thermal denaturation curves for SjGST alone or with 100 mM S-alkyl GSH in the absence (A) and presence (B) of 2 mM
GSH; (C) correlation between thermal shift at 100 mM alkyl-GSH and degree of inhibition against SjGST. Thermal shifts, where
applicable, represent the differences in Tm between vehicle control and compound-containing samples, respectively.
doi:10.1371/journal.pone.0036219.g002
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Inhibitors selected for the study
Three categories of GST inhibitors were chosen for this study
(Fig. 1). GSH analogs and mimetics (alkyl-GSHs, NBD-GS, and
Bis-(NB-GS)) represented GSH-competitive inhibitors [38,43]. EA
and NBD-8-OH represented the category of compounds known to
form conjugates with GSH [30]. Lastly, quercetin, myricetin, and
tannic acid belonged to the ligandin-type inhibitor category [30].
Although a range of inhibitory potencies have been reported for
these compounds in multiple studies spanning decades, we wished
to profile all of them using a recently developed sensitive
luminescence-based enzymatic assay [39]. The IC50 values derived
from the luciferase-coupled enzymatic assay are shown in Fig. 1
along with the compounds’ structures.
Due to the limited solubility of S-alkyl GSHs, a lack of
inhibitory saturation was observed at top concentrations tested,
making it impossible to derive IC50 values. Thus, the percent
inhibition caused by these molecules at a fixed concentration was
used to represent and compare their activity against SjGST. The
S-alkyl glutathione derivatives displayed alkyl-chain dependent
enzyme inhibitory activity with greater inhibition corresponding to
derivatives with longer alkyl chain, in agreement with previously
noted trends [44]: at 58 mM, 83% inhibition was obtained for S-
octyl GSH, 58% for S-hexyl GSH, and 35% for S-butyl GSH; S-
methyl GSH did not show detectable inhibition when tested at
concentrations up to 200 mM. Between the two GSH analogs, the
bivalent compound Bis-(NB-GS), exhibited an order of magnitude
lower IC50 than NBD-GS. The third NBD compound, NBD-8-
OH, and EA both produced submicromolar IC50s. Among the rest
Figure 3. Thermal shift concentration-response curves for S-alkyl GSH using SjGST: A) S-methyl GSH, B) S-butyl GSH, C) S-hexyl
GSH, D) S-octyl GSH. Thermal shifts represent the differences in Tm between vehicle control and compound-containing samples, respectively.
doi:10.1371/journal.pone.0036219.g003
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micromolar IC50 values, while tannic acid was the most potent
inhibitor tested, yielding a double digit nanomolar IC50.
SjGST thermal denaturation profiles
Thermal denaturation profiles of SjGST were recorded
following the fluorescence change of the environmentally sensitive
dye SYPRO Orange (Fig. 2 A and B). The profiles contained a
single transition and an asymmetric peak, with a maximum
fluorescence intensity achieved at approximately 60uC. The
decrease in fluorescence on the right-hand side of the peak is
typically attributed to aggregation and precipitation of the
denatured protein, as well as to the natural decrease in quantum
yield of the fluorescent dye at higher temperatures. A Tm of
53.060.02uC (n=2) was obtained with high reproducibility for the
apo protein (see raw-fluorescence plots of duplicate determination
of the melting profile for SjGST in Supplemental Figure S1); this
value was similar to those obtained by measuring SjGST thermal
denaturation through its residual enzymatic activity after heating
(Tm,51uC) [22] and by differential scanning calorimetry (Tm:
55.15–58.95uC at pH 7.5 using different scanning rates) [45].
Using differential scanning calorimetry, Quesada-Soriano et al.
also found that a single melt transition was consistently produced
at various SjGST concentrations. The clear monophasic thermal
transition of SjGST obtained under the DSF conditions here
permitted subsequent tests where compounds of interest were
included.
SjGST DSF profiles with GSH mimetics
SjGST thermal stability was tested in the presence of a series of
S-alkylglutathione derivatives (representative melting curves
shown in Fig. 2A). Ligand-induced protein stabilization effect
was apparent for all compounds tested, and protein Tm increased
with increasing concentrations of ligand (Fig. 3, square symbols in
all panels). The corresponding magnitudes of protein stabilization
were different among different S-alkylglutathione derivatives. The
rank order of thermal stabilization observed was: S-octyl GSH.S-
hexyl GSH.S-butyl GSH.S-methyl GSH. Overall, there was a
good correlation between the thermal shifts produced by the S-
alkyl GSHs and their inhibitory effects on SjGST (Fig. 2C).
When the S-alkylglutathiones were tested in the presence of
2 mM GSH (representative melting curves shown in Fig. 2B), a
concentration above the reported Km value chosen to ensure
adequate occupancy of the corresponding binding site, a ,4uC
enhancement in the thermal shift baseline was observed at low
compound concentrations, due to the stabilizing effect afforded by
GSH, but that enhancement gradually decreased as the compound
concentration increased, leading to the two curves converging
(Fig. 3). The converging effect became stronger as the alkyl chain
increased: S-methyl glutathione itself did not produce significant
thermal shift (,2uC) and the thermal shift differences between the
GSH-absent and GSH-present curves remained approximately
4uC, while the difference in thermal shifts at the top compound
concentrations was compressed to 1.8uC for both S-butyl and S-
hexyl glutathione, and further to 0.45uC for S-octyl glutathione.
Additional GSH analogs tested were Bis-(NB-GS) and NBD-
GS. Bis-(NB-GS) induced a very large thermal stabilization,
generating about twice the thermal shift produced by its
monovalent version NBD-GS (11.1uC vs. 5.9uC at 200 mM,
Fig. 4), in unison with the over 3-fold greater inhibitory potency of
Bis-(NB-GS) versus NBD-GS (0.67 mM versus 2.3 mM, Fig. 1).
Both Bis-(NB-GS) and NBD-GS displayed similar thermal shift
profiles to those observed for the S-alkylglutathiones: the thermal
shift enhancement produced in the presence of constant 2 mM
GSH became more compressed as the inhibitor concentration
increased. The converging trend between the thermal shift profiles
obtained in the presence and absence of GSH was more
pronounced for Bis-(NB-GS) than for NBD-GS: for Bis-(NB-GS),
the difference between the Tm under GSH-present and GSH-
absent condition decreased from the initial 4.8uC at concentration
zero to 1.2uC at 200 mM inhibitor, while the corresponding value
for NBD-GS only dropped from the initial 4.8uCt o4 uC.
SjGST DSF profiles with GSH conjugate-forming inhibitors
NBD-8-OH and ethacrynic acid (EA) produced similar thermal
shift profiles (Fig. 5): in the absence of GSH, while the former
failed to display any significant thermal stabilization effect and the
latter elicited only a 1.8uC thermal shift at the top concentration,
thermal stabilization effects induced by these two inhibitors
Figure 4. Thermal shift concentration-response curves using
SjGST in the absence and presence of 2 mM GSH for A) NBD-GS
and B) bis-(NB-GS). Thermal shifts represent the differences in Tm
between vehicle control and compound-containing samples, respec-
tively.
doi:10.1371/journal.pone.0036219.g004
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the test. Specifically, further enhancements of 10.5uC and 11.5uC
were observed at 200 mM NBD-8-OH and EA, respectively, when
GSH was present. It thus appeared that the strong thermal
stabilization of GST by these inhibitors was strictly dependent on
the presence of the glutathione co-substrate.
SjGST DSF profiles with ligandin type inhibitors
In the presence of GSH, quercetin, myricetin and tannic acid
produced profiles parallel to those obtained in its absence. Both
quercetin and myricetin increased the protein Tm by over 3uCa t
200 mM without GSH, with the corresponding GSH-present
curves simply upward-shifted by approximately 4uC across all
concentrations (Fig. 6 A/B). Tannic acid, which could be tested
only up to 12.5 mM due to interference with the DSF signal, also
produced parallel trends separated by approximately 4.5uC
(Fig. 6C). Thus, the stabilization afforded by the ligandin type
inhibitors tested here appeared to be independent from the
corresponding effect of GSH.
DSF signatures of human GST A1 and M1
The study was subsequently extended to human GST isozymes
by testing one representative compound from each category
against hGST A1 and M1 (hGST P1 was not pursued due to the
protein’s lack of clear melt transition, data not shown). Thermal
shift responses and glutathione-dependency trends of the inhibitors
tested against hGST A1 and hGST M1 were similar to those
obtained with SjGST, that is, a converging trend for S-octyl GSH
(Fig. 7A/D), a diverging trend for ethacrynic acid (Fig. 7B/E), and
a parallel trend for quercetin (Fig. 7C/F).
Discussion
The goal of this study was to apply GST as a model target in
order to investigate whether ligands’ mode of inhibition could be
discerned through DSF signatures. To this end, we examined the
thermal stability changes of SjGST, hGST A1 and hGST M1 in
the presence of three classes of inhibitors. By testing each inhibitor
in concentration-response format and by comparing the com-
pound-induced thermal stabilization effects in the absence and
presence of GST’s physiological substrate GSH, we derived
thermal shift profiles for each compound studied and found that
GST inhibitors from the same class showed similar DSF
signatures, implying a common mechanism of action for these
compounds. In turn, the three different classes of inhibitors
produced markedly different co-substrate dependency signatures,
consistent with their modes of action; the signatures derived in the
present study are presented in schematic form in Fig. 8.
GST interaction with GSH analogs
The compression phenomena observed for the S-alkylglu-
tathiones in the presence of GSH are consistent with these
compounds acting as competitive inhibitors of SjGST with respect
to GSH (Fig. 8A), as previously reported [43]; in addition, the
magnitudes of thermal stabilization observed here correlated well
with not only the S-alkylglutathiones’ inhibitory activity against
SjGST measured in this study but also with their binding affinities
against SjGST reported by Ortiz-Salmero ´n et al. [43]. The polar
G-site is conserved between parasitic and mammalian enzymes to
sequester GSH or the GSH moiety from GSH-analogs through
similar but specific hydrogen bonding interactions [27,46]. The H-
site has been found to vary at the sequence and structural level
[27], and it has been suggested that the alkyl side chains make
non-specific apolar contacts within the H-site, rendering addition-
al binding energy and subsequently tighter binding [46]. Thus, our
observation that a significantly higher degree of thermal shift was
achieved for compounds with longer alkyl chains is consistent with
the previous conclusions that increase in the length of the alkyl
chain results in a more hydrophobic environment and thus a
higher binding affinity contributed by the increased binding site
complementarity [47].
NBD-GS and Bis-(NB-GS) are reported competitive inhibitors
with respect to common GST substrates, such as GSH and CDNB
[38] and in our GSH dependency testing of GST thermal
stabilization both produced the same convergent trendlines. The
presence of the thioether group was suggested to be essential for
tight binding [40], in line with the single digit micromolar or
submicromolar potencies displayed by these compounds. Bis-(NB-
GS) is a symmetrical bivalent inhibitor of SjGST, designed to
occupy both active sites of the dimeric enzyme simultaneously. As
Figure 5. Thermal shift concentration response curves using SjGST in the absence and presence of GSH for the conjugate-formers
NBD-OH (A) and ethacrynic acid (EA, panel B). Thermal shifts represent the differences in Tm between vehicle control and compound-
containing samples, respectively.
doi:10.1371/journal.pone.0036219.g005
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‘‘multivalency’’ is a strategy to design compounds with increased
contacts with the protein’s active sites simultaneously, which could
potentially increase their binding affinity and selectivity [30,31].
The approach has been validated using existing bivalent ligands,
such as GS-CDNB conjugate and the large symmetrical dye
Cibacron Blue [38]. A thermodynamics study by Lyon et al.
attributed improved bivalent compound binding affinities to GST
to their significantly more favorable binding enthalpy [38]. This is
in agreement with the large protein stabilization effect observed
with Bis-(NB-GS) in our study, as the magnitude of thermal shift is
affected by several factors: for a given protein at a fixed
concentration, the ligand concentration and its binding affinity,
along with enthalpy and heat capacity of ligand binding,
determine the extent of thermal shift [5,11].
GST interaction with GSH conjugate-forming inhibitors
Several classes of GSTs have been reported to be sensitive to
product inhibition achieved through the formation of covalent
GSH conjugate [48] (Fig. 8B). In contrast to NBD-GS and Bis-
(NB-GS), NBD-8-OH does not contain a GSH moiety, but is
designed to be a suicide inhibitor for GSTs due to its ability to
form a GSH conjugate during the reaction [40]. This notion was
supported by the significantly enhanced thermal stabilization effect
induced by NBD-8-OH when GSH was present (Fig. 5). Through
spectrophotometric and fluorometric analyses using an analog of
NBD-8-OH, NBDHEX (6-methylene substituent in the S-side
chain instead of the 8 methylenes contained within NBD-8-OH),
Ricci et al. found that the inhibitor bound to the H-site and that
the formation of GSH conjugate with the concomitant release of
6-mercapto-1-hexanol was greatly facilitated in the presence of the
enzyme [40]. The strong association constants for the NBD-GS
adduct determined for several GSTs in that study are hereby
supported by the observation of a large thermal stabilization
produced by NBD-8-OH/GSH and the very close resemblance of
the thermal shift profiles between NBD-8-OH/GSH and NBD-
GS/GSH.
The other model inhibitor used here, EA, is a potent diuretic
drug and an inhibitor of multiple GSTs. Its conjugate with GSH,
EA-GSH, suggested to be formed by Michael addition, is also a
strong GST inhibitor [27,28,49]. Co-crystal structures of EA-GSH
conjugate in complex with human a and p GST indicate the
requirement of bound glutathione for EA to dock into the H site in
a productive binding mode, as EA itself was found to bind in a less
optimal mode to the H site (non-productive mode) with the G site
occupied by solvent molecules [23,28]. The position in which EA
bound in the H site of the enzyme was also found to be similar to
the hexyl moiety of the S-hexyl-GSH complex crystal structure
[28]. Thus, the presence of GSH in the GST active site has been
hypothesized to serve as a molecular recognition element
necessary for EA to efficiently interact with GSTs [23]. In concert
with these analyses, we observed a minimal thermal stabilization
effect exerted by EA alone while a dramatically higher
stabilization was obtained at the same EA concentration in the
presence of GSH.
GST interaction with ligandin-type inhibitors
Another type of GST inhibitors have been referred to as the
ligandin type inhibitors, represented by hydrophobic planar
aromatic compounds with anionic functional groups, such as
porphyrins, polyphenols or tocopherols [30]. The exact binding
site for ligandin type inhibitors remains to be fully characterized,
but there has been speculation that their binding site (referred to as
L-site) may be of a degenerate nature. Crystallographic studies by
Figure 6. Thermal shift concentration-response curves using
SjGST in the absence and presence of 2 mM GSH for A)
quercetin, B) myricetin and C) tannic acid. Thermal shifts
represent the differences in Tm between vehicle control and
compound-containing samples, respectively.
doi:10.1371/journal.pone.0036219.g006
Thermal Shift Signatures as MOA Indicators
PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e36219Oakley et al. suggested that the L-site was located in the H-site for
hGST P1 [33] while McTigue et al. provided evidence that the L-
site was located along the dimer interface in SjGST and was the
binding site for the anti-schistosomiasis agent praziquantel [21].
Findings from additional studies led to the notion that there might
be an expansive ligandin site that spanned the intersubunit cleft
and the H-site [30]. Multiple binding modes for ligandin-type
inhibitors may exist, as extensive members of ligandin-type
inhibitors, such as plant polyphenols and tocopherols, have been
shown to be competitive towards hydrophobic substrate or
involved in active site covalent modification [50] and will likely
be different for the different chemical structural classes. The
inhibition mechanisms of these compounds await further investi-
gation.
Herein, we performed analyses of 3 ligandin type inhibitors,
quercetin, myricetin and tannic acid. The parallel concentration-
response thermal shift curves observed by us for these compounds
in the presence and absence of GSH are indicative of stabilizing
effects exerted by the inhibitors being independent of those caused
by GSH and thus appear to support the mechanism where these
compounds inhibit the enzyme by docking into the H site without
significant interference with the G-site, that is, by being non-
competitive with respect to GSH (Fig. 8C). Using GST isolated
from rat livers, Merlos et al. showed that several flavonoids,
Figure 7. Thermal shift concentration-response curves using hGSTA1-1 in the absence and presence of 2 mM GSH for A) S-octyl
GSH, B) ethacrynic acid (EA), C) quercetin, and using hGSTM1-1 for D) S-octyl GSH, E) EA, and F) quercetin. Thermal shifts represent the
differences in Tm between vehicle control and compound-containing samples, respectively.
doi:10.1371/journal.pone.0036219.g007
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both GSH and CDNB [51].
The present study is, to our knowledge, the first to interrogate
compound mechanism of inhibition for GST enzymes through
fluorescence-based thermal shift assays. Based on the relative
shapes of the thermal shift profiles produced with and without the
native co-substrate GSH, an indication of compound inhibition
mechanism is provided. Converging, diverging and parallel DSF
signatures were linked to competitive, conjugate formation
(product inhibition), and ligandin-type inhibition. Although
electrophile binding site and substrate binding mode have been
characterized for SjGST and human isozymes using other
methods, such as fluorescence spectroscopy [52], ITC [43,52],
crystallography and molecular docking [27], our study demon-
strates that DSF can provide complementary information on
protein-ligand binding pathways using very simple experimental
setup which allows the rapid profiling of multiple inhibitors. The
application of DSF as a tool to probe enzyme-ligand interaction
mechanisms can be expanded to a wide range of protein classes
and is expected to be particularly useful in situations where
detailed enzymological and spectroscopic studies are difficult to
implement.
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Figure S1 Reproducibility of thermal denaturation
profiles.
(DOC)
Acknowledgments
We thank P. Shinn and D. Van Leer for compound management support.
Author Contributions
Conceived and designed the experiments: WAL AS. Performed the
experiments: WAL. Analyzed the data: WAL AS. Contributed reagents/
materials/analysis tools: WAL AS. Wrote the paper: WAL AS.
Figure 8. Schematic illustration of different inhibition mechanisms and the associated DSF signatures: A) GSH-competitive
inhibition; B) conjugate-formation; C) ligandin-type.
doi:10.1371/journal.pone.0036219.g008
Thermal Shift Signatures as MOA Indicators
PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e36219References
1. Todd MCMD, Nelen MI (2005) Affinity assays for decrypting protein targets of
unknown function. Drug Discovery Today: Technologies 2: 267–273.
2. Cummings MD, Farnum MA, Nelen MI (2006) Universal screening methods
and applications of ThermoFluor. J Biomol Screen 11: 854–863.
3. Pantoliano MW, Petrella EC, Kwasnoski JD, Lobanov VS, Myslik J, et al. (2001)
High-density miniaturized thermal shift assays as a general strategy for drug
discovery. J Biomol Screen 6: 429–440.
4. Poklar N, Lah J, Salobir M, Macek P, Vesnaver G (1997) pH and temperature-
induced molten globule-like denatured states of equinatoxin II: a study by UV-
melting, DSC, far- and near-UV CD spectroscopy, and ANS fluorescence.
Biochemistry 36: 14345–14352.
5. Vedadi M, Niesen FH, Allali-Hassani A, Fedorov OY, Finerty PJ, Jr., et al.
(2006) Chemical screening methods to identify ligands that promote protein
stability, protein crystallization, and structure determination. Proc Natl Acad
Sci U S A 103: 15835–15840.
6. Ericsson UB, Hallberg BM, Detitta GT, Dekker N, Nordlund P (2006)
Thermofluor-based high-throughput stability optimization of proteins for
structural studies. Anal Biochem 357: 289–298.
7. Niesen FH, Berglund H, Vedadi M (2007) The use of differential scanning
fluorimetry to detect ligand interactions that promote protein stability. Nat
Protoc 2: 2212–2221.
8. Bergsdorf C, Ottl J (2010) Affinity-based screening techniques: their impact and
benefit to increase the number of high quality leads. Expert Opinion in Drug
Discovery 5: 1095–1107.
9. Carver TE, Bordeau B, Cummings MD, Petrella EC, Pucci MJ, et al. (2005)
Decrypting the biochemical function of an essential gene from Streptococcus
pneumoniae using ThermoFluor technology. J Biol Chem 280: 11704–11712.
10. Lo MC, Aulabaugh A, Jin G, Cowling R, Bard J, et al. (2004) Evaluation of
fluorescence-based thermal shift assays for hit identification in drug discovery.
Anal Biochem 332: 153–159.
11. Matulis D, Kranz JK, Salemme FR, Todd MJ (2005) Thermodynamic stability
of carbonic anhydrase: measurements of binding affinity and stoichiometry using
ThermoFluor. Biochemistry 44: 5258–5266.
12. Bullock AN, Debreczeni JE, Fedorov OY, Nelson A, Marsden BD, et al. (2005)
Structural basis of inhibitor specificity of the human protooncogene proviral
insertion site in moloney murine leukemia virus (PIM-1) kinase. J Med Chem 48:
7604–7614.
13. Zubriene A, Matuliene J, Baranauskiene L, Jachno J, Torresan J, et al. (2009)
Measurement of nanomolar dissociation constants by titration calorimetry and
thermal shift assay - radicicol binding to Hsp90 and ethoxzolamide binding to
CAII. Int J Mol Sci 10: 2662–2680.
14. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, et al. Selective inhibition
of BET bromodomains. Nature 468: 1067–1073.
15. Niesen FH, Schultz L, Jadhav A, Bhatia C, Guo K, et al. High-affinity inhibitors
of human NAD-dependent 15-hydroxyprostaglandin dehydrogenase: mecha-
nisms of inhibition and structure-activity relationships. PLoS One 5: e13719.
16. Auld DLS, Thorne N, Lea WA, Maloney DJ, Shen M, Rai G, Battaile K,
Thomas CJ, Simeonov A, Hanzlik RP, Inglese J (2010) Molecular Basis for the
High Affinity Binding and Stabilization of Firefly Luciferase by PTC124. Proc
Natl Acad Sci USA 107: 4878–4883.
17. Mannervik B, Danielson UH, Ketterer B (1988) Glutathione Transferases-
Structures and Catalytic Activity. Critical Reviews in Biochemistry and
Moelcular Biology 23: 283–337.
18. Armstrong RN (1997) Structure, catalytic mechanism, and evolution of the
glutathione transferases. Chem Res Toxicol 10: 2–18.
19. Khan MA, Tania M, Zhang D, Chen H (2010) Antioxidant enzymes and
cancer. Chin J Cancer Res 22: 87–92.
20. Xu X, Lemaire C, Grzych JM, Pierce RJ, Raccurt M, et al. (1997) Expression of
a Schistosoma mansoni 28-kilodalton glutathione S-transferase in the livers of
transgenic mice and its effect on parasite infection. Infect Immun 65:
3867–3874.
21. McTigue MA, Williams DR, Tainer JA (1995) Crystal structures of a
schistosomal drug and vaccine target: glutathione S-transferase from Schisto-
soma japonica and its complex with the leading antischistosomal drug
praziquantel. J Mol Biol 246: 21–27.
22. Kaplan W, Husler P, Klump H, Erhardt J, Sluis-Cremer N, et al. (1997)
Conformational stability of pGEX-expressed Schistosoma japonicum glutathi-
one S-transferase: a detoxification enzyme and fusion-protein affinity tag.
Protein Sci 6: 399–406.
23. Cameron AD, Sinning I, L’Hermite G, Olin B, Board PG, et al. (1995)
Structural analysis of human alpha-class glutathione transferase A1-1 in the apo-
form and in complexes with ethacrynic acid and its glutathione conjugate.
Structure 3: 717–727.
24. Le Trong I, Stenkamp RE, Ibarra C, Atkins WM, Adman ET (2002) 1.3-A
resolution structure of human glutathione S-transferase with S-hexyl glutathione
bound reveals possible extended ligandin binding site. Proteins 48: 618–627.
25. Rufer AC, Thiebach L, Baer K, Klein HW, Hennig M (2005) X-ray structure of
glutathione S-transferase from Schistosoma japonicum in a new crystal form
reveals flexibility of the substrate-binding site. Acta Crystallogr Sect F Struct Biol
Cryst Commun 61: 263–265.
26. Kursula I, Heape AM, Kursula P (2005) Crystal structure of non-fused
glutathione S-transferase from Schistosoma japonicum in complex with
glutathione. Protein Pept Lett 12: 709–712.
27. Cardoso RM, Daniels DS, Bruns CM, Tainer JA (2003) Characterization of the
electrophile binding site and substrate binding mode of the 26-kDa glutathione
S-transferase from Schistosoma japonicum. Proteins 51: 137–146.
28. Oakley AJ, Rossjohn J, Lo Bello M, Caccuri AM, Federici G, et al. (1997) The
three-dimensional structure of the human Pi class glutathione transferase P1-1 in
complex with the inhibitor ethacrynic acid and its glutathione conjugate.
Biochemistry 36: 576–585.
29. Reinemer P, Dirr HW, Ladenstein R, Huber R, Lo Bello M, et al. (1992) Three-
dimensional structure of class pi glutathione S-transferase from human placenta
in complex with S-hexylglutathione at 2.8 A resolution. J Mol Biol 227:
214–226.
30. Mahajan S, Atkins WM (2005) The chemistry and biology of inhibitors and pro-
drugs targeted to glutathione S-transferases. Cell Mol Life Sci 62: 1221–1233.
31. Mathew N, Kalyanasundaram M, Balaraman K (2006) Glutathione S-
transferase (GST) inhibitors. Expert Opinion on Therapeutic Patents 16:
431–444.
32. Eaton DL, Bammler TK (1999) Concise review of the glutathione S-transferases
and their significance to toxicology. Toxicol Sci 49: 156–164.
33. Oakley AJ, Lo Bello M, Nuccetelli M, Mazzetti AP, Parker MW (1999) The
ligandin (non-substrate) binding site of human Pi class glutathione transferase is
located in the electrophile binding site (H-site). J Mol Biol 291: 913–926.
34. Wang T, Arifoglu P, Ronai Z, Tew KD (2001) Glutathione S-transferase P1-1
(GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction
with the C terminus. J Biol Chem 276: 20999–21003.
35. Laborde E () Glutathione transferases as mediators of signaling pathways
involved in cell proliferation and cell death Cell Death Differ 17: 1373–1380.
36. Cho SG, Lee YH, Park HS, Ryoo K, Kang KW, et al. (2001) Glutathione S-
transferase mu modulates the stress-activated signals by suppressing apoptosis
signal-regulating kinase 1. J Biol Chem 276: 12749–12755.
37. van Bladeren PJ, van Ommen B (1991) The inhibition of glutathione S-
transferases: mechanisms, toxic consequences and therapeutic benefits. Phar-
macol Ther 51: 35–46.
38. Lyon RP, Hill JJ, Atkins WM (2003) Novel class of bivalent glutathione S-
transferase inhibitors. Biochemistry 42: 10418–10428.
39. Yasgar ASJ, Zhou W, Wang H, Huang F, Murphy N, Abel EL, DiGiovanni J,
Inglese J, Simeonov A (2010) A High-throughput 1536-well luminescence Assay
for Glutathione S-Transferase Activity. ASSAY Drug Dev Technol 8: 200–211.
40. Ricci G, De Maria F, Antonini G, Turella P, Bullo A, et al. (2005) 7-Nitro-2,1,3-
benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione S-
transferases. Mechanism of action of potential anticancer drugs. J Biol Chem
280: 26397–26405.
41. Nieslanik BS, Atkins WM (2000) The catalytic Tyr-9 of glutathione S-transferase
A1-1 controls the dynamics of the C terminus. J Biol Chem 275: 17447–17451.
42. Michael S, Auld D, Klumpp C, Jadhav A, Zheng W, et al. (2008) A robotic
platform for quantitative high-throughput screening. Assay Drug Dev Technol
6: 637–657.
43. Ortiz-Salmeron E, Yassin Z, Clemente-Jimenez MJ, Las Heras-Vazquez FJ,
Rodriguez-Vico F, et al. (2001) A calorimetric study of the binding of S-
alkylglutathiones to glutathione S-transferase. Biochim Biophys Acta 1548:
106–113.
44. Askelof P, Guthenberg C, Jakobson I, Mannervik B (1975) Purification and
Characterization of Two Glutathione S-Aryltransferase Activities from Rat
Liver. Biochem J 147: 513–522.
45. Quesada-Soriano I, Garcia-Maroto F, Garcia-Fuentes L (2006) Kinetic study on
the irreversible thermal denaturation of Schistosoma japonicum glutathione S-
transferase. Biochim Biophys Acta 1764: 979–984.
46. Erhardt J, Dirr H (1996) Effect of glutathione, glutathione sulphonate and S-
hexylglutathione on the conformational stability of class pi glutathione S-
transferase. FEBS Lett 391: 313–316.
47. Andujar-Sanchez M, Smith AW, Clemente-Jimenez JM, Rodriguez-Vico F, Las
Heras-Vazquez FJ, et al. (2005) Crystallographic and thermodynamic analysis of
the binding of S-octylglutathione to the Tyr 7 to Phe mutant of glutathione S-
transferase from Schistosoma japonicum. Biochemistry 44: 1174–1183.
48. Meyer DJ (1993) Significance of an unusually low Km for glutathione in
glutathione transferases of the alpha, mu and pi classes. Xenobiotica 23:
823–834.
49. Awasthi S, Srivastava SK, Ahmad F, Ahmad H, Ansari GA (1993) Interactions
of glutathione S-transferase-pi with ethacrynic acid and its glutathione
conjugate. Biochim Biophys Acta 1164: 173–178.
50. van Zanden JJ, Ben Hamman O, van Iersel ML, Boeren S, Cnubben NH, et al.
(2003) Inhibition of human glutathione S-transferase P1-1 by the flavonoid
quercetin. Chem Biol Interact 145: 139–148.
51. Merlos M, Sanchez RM, Camarasa J, Adzet T (1990) Flavonoids as inhibitors of
rat liver cytosolic glutathione S-transferase. Experientia 47: 616–619.
52. Yassin Z, Ortiz-Salmeron E, Garcia-Maroto F, Baron C, Garcia-Fuentes L
(2004) Implications of the ligandin binding site on the binding of non-substrate
ligands to Schistosoma japonicum-glutathione transferase. Biochim Biophys
Acta 1698: 227–237.
Thermal Shift Signatures as MOA Indicators
PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e36219